NEELAM, A.; KANAKI, A. Efficacy and safety of remogliflozin etabonate in type 2 diabetes mellitus patients in a tertiary care hospital. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 10, n. 4, p. 353–356, 2021. DOI: 10.18203/2319-2003.ijbcp20211014. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/4535. Acesso em: 23 oct. 2025.